Examples of using Rrms in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
RRMS McDonald criteria.
It is not clear why RRMS changes in SPMS.
RRMS is the most common form of the disease.
It underlines the problem of selecting the optimal treatment of patients with RRMS.
In RRMS patients experience relapses followed by periods of recovery.
To enter the study takes the criterion EDSS-and with RRMS to 5.5, the PPMS the kod 6.5.
Patients with RRMS, with at least 2 relapses within the prior 3 years, and 1 relapse in the prior year, with an EDSS score of≤5.0.
Study 3(phase 2 study CAMMS223)evaluated the safety and efficacy of LEMTRADA in patients with RRMS over the course of 5 years.
The first such drugs for the treatment of RRMS were registered in the world in the first half of the 1990s.
Due to operational reliability the reporting of records of transactions, including orders to trade,is performed through Registered Reporting Mechanisms RRMs.
Secondary progressive MS(SPMS): In the course of time most patients with RRMS develop secondary progressive MS, above all with insufficient therapy.
The safety and efficacy of LEMTRADA were evaluated in 3randomised, rater-blinded, active-comparator clinical trials in patients with RRMS.
At this point most of the drug is registered for the treatment of RRMS a, while a drug is registered for the treatment of primary progressive MS PPMS.
It is now known that the localization and the number of such lesions on MRI are important for prognosistransition CIS in definite relapsing-remitting MS RRMS.
One study that followed people with RRMS a more than twenty years has shown that early initiation of treatment DMT therapy reduces mortality in patients.
Before the advent of drugs that the disease may be modified,in half of the patients with RRMS within, from 10 years developed SPMS.
The table below is based on thepooled safety data up to 24 months from RRMS patients treated with LEMTRADA 12 mg/day for 5 consecutive days at study entry and for 3 consecutive days at Study Month 12.
Although at present there is no medicine that would completely stopMS, Numerous studies have shown a marked beneficial effect DMT therapy in patients with RRMS a.
The results from the TOPIC study confirmed the efficacy of teriflunomide in RRMS including early RRMS with first clinical demyelinating event and MRI lesions disseminated in time and space.
The study's primary objective is to evaluate the dose response of 30 mg/day and 45 mg/day ofIMU-838, once daily, for the treatment of RRMS based on MRI assessments.
The results of our studies suggest animportant role of intestinal microflora in the pathogenesis of RRMS, and it should not surprise us because the bacteria that live in our intestines constantly entering the reaction to our immune systems.
LEMTRADA contains the active substance alemtuzumab, which is used to treat a form of multiplesclerosis(MS) in adults, called relapsing remitting MS RRMS.
Relapsing, remitting multiple sclerosis(RRMS): 85 to 90% of all patients have this form of MS. It is characterized by so-called attacks, phases of neurological symptoms which usually partially or completely resolve within a few weeks.
Very important role in this regard has MRI findings demyelinating plaques in the spinal cord, not only simplify the diagnosis of MS, but also in the forecastfaster conversion CIS in definitive form RRMS a.
Based on the results of Analysis ofVariance(ANOVA), body weight is the main covariate of exposure(by Cmax and AUC) in relapsing remitting multiple sclerosis(RRMS) subjects, but did not affect safety and efficacy measures evaluated in the clinical studies.
In the gut of patients with RRMS, and in the periods just before the relapse, notes the change of intestinal microflora and the corresponding proliferation of a certain type of white blood cells that are considered fundamental for the development of pathology", concludes the staff of the Institute hospital group Saint Donat.
Comparable results were shown in a replicate 2-year randomised, double-blind, placebo-controlled Phase III study on fingolimod in 1,083 patients(n=358 on 0.5 mg, 370 on 1.25 mg,355 on placebo) with RRMS D2309; FREEDOMS 2.
Although at present there is no medicine that would completely stopMS, Numerous studies have shown a marked beneficial effect DMT therapy in patients with RRMS a. Treatment DMT therapy significantly reduces the number of relapses and the number of births of demyelinating lesions on MRI.
